ID

40002

Description

Standard Data Tabulation Model (SDTM) by the Clinical Data Interchange Standards Consortium (CDISC) Based on SDTM v1.7 and the implementation guide SDTMIG v3.3 (for human clinical trials). Quote from https://www.cdisc.org/standards/foundational/sdtmig: "Where the SDTM provides a standard model for organizing and formatting data for human and animal studies, the SDTMIG is intended to guide the organization, structure, and format of standard clinical trial tabulation datasets. It was developed to support data submitted to a regulatory authority, such as the US Food and Drug Administration (FDA), but is not restricted to use in regulated submissions. SDTM is one of the required standards that sponsors must use as specified in the FDA’s Data Standards Catalog (see section II.C) for NDA, ANDA, and certain BLA submissions effective December 2016. For more information, please visit the Guidance on Standardized Data." Domains and Items from other implementation guides (e.g. SDTM-PGx, SDTM-MD) are not included. Please refer to CDISC for information on the implementation of SDTM and associated CDISC standards, do not rely solely on this adaption of CDISC standards. Codelists from the SDTM Terminology included as far as possible in this general version of SDTM (e.g. in the Findings About Domain they are not included, as they depend on the test/result/domain, they are associated with, e.g. COPD Findings About, Cardiovascular Findings About, ...; other test-specific codelists from other domains). Included are the complete codelists referenced in SDTM v1.7 or SDTMIG v3.3, they may need to be constrained depending on the domain or the specific use case. Codelists taken from NCI page https://www.cancer.gov/research/resources/terminology/cdisc in November 2019. CDISC Intellectual Property Policy Version 1.1 (August 15th 2014) Purpose: In its role of leading the development of standards, CDISC must protect those standards to ensure that, to the extent practicable, they remain neutral, open, compensation (royalty)-free, and without encumbering ties to prior intellectual property. This Intellectual Property Policy (“Policy”) is designed to facilitate the activities of CDISC in promotion of such open Standards, to maximize the adoption of such Standards by protecting against the ownership of such Standards by one party and to protect the legitimate intellectual property rights of Contributors.This Policy ensures that CDISC is in accordance with its Bylaws, other Policies and basic Principles.For more information on CDISC, its Bylaws, Strategic Plan, other Policies and basic Principles, please see the CDISC website at www.cdisc.org. Definitions: 2.1“Affiliate” means any entity that directly or indirectly controls, is controlled by, or is under common control with, another entity, so long as such control exists. “Control” means direct or indirect beneficial ownership of or the right to exercise (a) more than fifty percent (50%) of the voting stock or equity in an entity; or (b) more than fifty percent (50%) of the relevant ownership interest or decision-making authority representing the right to make the decisions for the subject entity in the event that there is no voting stock or equity. In the event such control ceases to exist, such Affiliate will be deemed to have withdrawn as a Member, pursuant to the terms set forth in the withdrawal provisions in Section 8. 2.2“CDISC Group” means any CDISC “Working Team,” “Support Team,” “Task Force,” technical working group, or sub-group of a CDISC team or group. 2.3“Contribution” means any material, suggestion, or other submission offered by a Participant in the process of developing a Draft Standard or Final Standard for the purpose of incorporating such submission into a Final Standard, provided that such submission either (a) exists in a tangible form of expression (including in electronic media); or (b) is a verbal statement that is memorialized in written documentation (such as meeting minutes or a draft standard) and is either confirmed or not objected to by such Participant within fifteen (15) calendar days after its receipt of such memorialization. 2.4“Draft Standard” means any CDISC standard or specification developed by a CDISC Group, prior to adoption and publication as a Final Standard. 2.5“Final Standard” means any CDISC standard adopted and published by CDISC as a Final (production version) Standard. 2.6“Licensee’s Product(s)” means only those specific portions of products (software, tools, data formats, other products or combinations thereof), not the product as a whole, that implement and are compliant with the relevant Required Portions of a Final Standard. 2.7 “Member” means all classes of CDISC membership as set forth in CDISC documentation and their Affiliates, including Corporate Benefactors, Corporate Sponsors, Corporate Members and Associate Members. 2.8“Necessary Claims” means those claims in any patent or patent application in any jurisdiction in the world, excluding design patents and design registrations, that would necessarily be infringed by an implementation of those portions of a particular Final Standard within the scope of the CDISC Group charter in effect at the time such Final Standard was developed. A patent claim is “necessarily infringed” only when it is not possible to avoid infringing it because there is no commercially reasonable, non-infringing alternative for implementing the Required Portions of such Final Standard. Notwithstanding the foregoing, Necessary Claims do not include any claims: (i) that may be contained in the same patent as Necessary Claims but are not themselves Necessary Claims; (ii) that cover solely any portions of any product and any combinations thereof that are not required for compliance with the Final Standard; (iii) that cover any enabling technologies that may be necessary to make or use any product or portion thereof that complies with a Final Standard, but are not themselves expressly set forth in the Final Standard (e.g., semiconductor manufacturing technology, compiler technology, object oriented technology, operating system technology, computers, networks, connectivity protocols, or the like); (iv) that cover implementation examples or reference implementations in the text of a Final Standard; or (v) that cover the implementation of other published specifications/standards developed elsewhere and merely referred to in the body of a Final Standard.Since this definition of Necessary Claims focuses solely on Final Standards, not Draft Standards, for purposes of applying the disclosure obligations in Section 5 of this Policy, references to disclosures of Non-Contributed Necessary Claims “covering a Draft Standard” shall be understood to assume that the Draft Standard at issue would ultimately be adopted, without modification, as a Final Standard. 2.9 “Non-Contributed Necessary Claims” means those Necessary Claims that cover not a Participant’s own Contribution but either: (a) the Contribution of another party; or (b) material that is otherwise included in a Final Standard. 2.10 “Participant” means any party that: (1) formally joins a CDISC Group as a listedparticipant; or (2) makes a Contribution to a CDISC Group; or (3) attends one (1) or more meeting(s)/teleconference(s) of a CDISC Group (in person or by telephone) within a one-year period. Participants and other parties must sign (either in writing or electronically) the document attached to this Policy as Attachment A before formally joining, taking part in, or making a Contribution to each particular CDISC Group. Note: A Participant may be an individual acting in its own individual capacity or an organization, and may or may not be a CDISC Member organization or from a CDISC Member organization. If the Participant is an organization, the Participant may be represented in CDISC Groups by a Representative. 2.11“Representative” means an individual who is identified to CDISC as having authority to participate in CDISC or a CDISC Group on behalf of the Participant organization by which s/he is employed. The actions and statements of such individual(s) will be deemed to legally bind such Representative’s Participant organization and its affiliates. 2.12“Required Portion” means a portion of a Final Standard that is required for an implementation to comply with a Final Standard (also known as a “normative” or “mandatory” portion), but not including any elements that are required solely for conformance with any optional (i.e., “non-normative,” “non-mandatory”) portion(s) of a Final Standard; provided, however, that where a Final Standard contains a choice of two or more portions, and implementing any one of the portions is required to comply with the Final Standard (i.e., mutually exclusive required options), each such portion shall be deemed to be a Required Portion. 3 Compensation-free Patent License Commitment Each Participant agrees that, upon request and subject to Sections 5.1 and 8, it will grant, to all parties implementing a Final Standard developed by a CDISC Group in which it was a Participant, a nonexclusive, compensation-free (i.e., no royalty or other fee), nontransferable, non-sublicensable, worldwide, and otherwise reasonable and non-discriminatory license under such Participant’s Necessary Claims covering such Final Standard, solely to make, have made, use, import, offer to sell, sell, lease, and otherwise distribute and dispose of Licensee’s Products that implement such Final Standard; provided, however, that such commitment to license shall not apply to any Necessary Claims for which the Participant does not have the right to license without obligation of payment of royalties or other material consideration by such Participant to an unaffiliated third party. The commitment to license arising under this Section shall be effective as of the date the party was first deemed to be a Participant in the applicable CDISC Group. 4 Copyright Ownership and Licenses 4.1Copyright Ownership in Final Standards. CDISC shall own the copyright in Final Standards developed by CDISC, subject to the underlying copyright rights of the contributing Participants and other copyright owners. Any publication of a Final Standard shall contain an appropriate copyright notice in the name of CDISC. 4.2Copyright License for Contributions. Upon submitting a Contribution, each contributing Participant grants and agrees to grant (i) to each Participant a non-exclusive, worldwide, perpetual, nontransferable, compensation-free license under the Participant’s copyright rights in the Contribution to reproduce, publish, display, perform, distribute, and create derivative works of the Contribution, solely for the purpose of creating and promoting the Draft Standard and Final Standard for which such Contribution was submitted, and (ii) to CDISC a non-exclusive, worldwide, perpetual, irrevocable, compensation-free license to reproduce, publish, display, perform, distribute, and create derivative works of such Contribution (including any Draft Standard, Final Standard, or portion or derivative thereof incorporating the Contribution), and to freely sublicense such rights through multiple tiers, for the purpose of creating and promoting the Draft Standard and Final Standard and for other CDISC activities. Upon the adoption of a Final Standard, CDISC hereby grants and agrees to grant to all Participants and without limiting the generality of the licenses granted herein is also authorized to grant to other parties a nonexclusive, compensation-free, non-transferable, non-sublicensable, worldwide, perpetual, copyright license to reproduce, publish, display, perform, and distribute the Final Standard solely for the purpose of creating and distributing a Licensee’s Product(s) and any accompanying documentation. CDISC may also sublicense such copyright rights to reproduce, publish, display, perform, and distribute the Final Standard to another standard development organization solely for the purpose of adopting the same standard, subject to the relevant CDISC approval procedures, if any, for such further distribution by other organizations as may be established by the CDISC Board of Directors. All reproductions of a Draft Standard or Final Standard shall include all copyright notices, disclaimers, limitations of liability, and other such statements contained in the original. 5 Treatment of Non-Contributed Necessary Claims 5.1Review Period / Licensing Obligations for Non-Contributed Necessary Claims. To ensure that all Participants have the opportunity to review each proposed Draft Standard as a complete document for purposes of identifying Non-Contributed Necessary Claims, CDISC shall, at least thirty (30) calendar days prior to the finalization of the Draft Standard, notify all Participants via e-mail and post the Draft Standard on the CDISC website for open review. During the review period, each Participant in the CDISC Group that developed the Draft Standard under review (as well as others that choose to take part in such review) shall: (a) review the Draft Standard; (b) disclose, pursuant to Section 5.2, any of its Non-Contributed Necessary Claim(s) covering such Draft Standard that the Participant is not willing to license to all implementers of the resulting Final Standard under the compensation-free and otherwise reasonable and non-discriminatory commitment of Section 3; and (c) submit, prior to the end of the review period, a written licensing declaration for any Non-Contributed Necessary Claim disclosed under subclause (b) indicating whether the Participant will commit to license such disclosed claim(s) at least on reasonable and non-discriminatory (“RAND”) terms and conditions (note, Necessary Claims that cover one’s own Contributions must be licensed compensation-free pursuant to Section 3). If a Participant declares its intent under subclause (c) to license the disclosed Non-Contributed Necessary Claim on a RAND basis, it will have a RAND licensing obligation for such disclosed claim to all implementers of the Final Standard. If instead the Participant declares its intent under subclause (c) not to commit to at least RAND licensing for such disclosed claim and withdraws prior to the end of the review period, such Participant will have no licensing obligation for such disclosed claim. If, however, the Participant fails to comply with either of these two options, it will be deemed to have committed to the compensation-free and otherwise reasonable and non-discriminatory licensing obligation of Section 3 (“Default Licensing Obligation”) for such disclosed claim. Any other Non-Contributed Necessary Claims of such Participants that were not disclosed prior to the end of the review period shall also be subject to the Default Licensing Obligation. For the avoidance of doubt, the Default Licensing Obligation (which obligation actually arose under Section 3 and which the Participant failed to avoid by complying with the disclosure/licensing declaration and (if applicable) withdrawal provvisions of this Section) applies to all of a Partticipant’s undisclosed Non-Contributed Necessary Claims covering the Final Standard ultimately resulting from the Draft Standard under review, despite the lack of actual and personal knowledge thereof by any individual Representative who participates in such CDISC Group on behalf of such Participant. In the event that a Participant discloses its intention not to make at least a RAND licensing commitment for certain of its Non-Contributed Necessary Claims, the CDISC Group that developed the affected Draft Standard will, in consultation with the CDISC Board of Directors, determine how best to proceed, such as by attempting to develop a revised version of the Draft Standard that works around the potentially blocking patent claims. If, after the review period ends, a Draft Standard is substantially modified, a subsequent review period shall be conducted, under the terms of Section 5.1, before the revised Draft Standard is adopted and published as a Final Standard. 5.2Minimum Contents of Disclosure. With respect to Non-Contributed Necessary Claims in issued patents and published patent applications subject to disclosure under Section 5.1, a Participant must disclose, at a minimum, the identity of the patent rights holder and/or applicant and the patent number or application number. With respect to unpublished patent applications subject to disclosure under Section 5.1, a Participant must disclose, at a minimum, the existence of the application containing the asserted Non-Contributed Necessary Claim(s) and identify the portion(s) of the Draft Standard on which such asserted claim(s) read(s), but need not disclose identifying information (e.g., application number, application contents). Nothing herein precludes broader disclosure of unpublished patent applications on a voluntary basis or pursuant to a non-disclosure agreement. If any disclosed patent or patent application contains Necessary Claims which, if licensed, would require a payment of royalties or other material consideration to an unaffiliated third party, the Participant must also highlight this fact in its disclosure statement. Nothing in this Section or this Policy imposes any duty on any Representative or Participant to perform a patent search or other search of intellectual property portfolios. 6 CDISC Processes; Statement Regarding Patent Disclosures and Other Issues 6.1CDISC Records of Patent Disclosures / Licensing Declarations. The CDISC President shall promptly provide to the CDISC Board of Directors, in writing, the information contained in any patent disclosure. CDISC shall maintain a file, accessible by the public, which includes all patent disclosure statements and licensing declarations received for any Draft Standard or Final Standard. CDISC shall also provide such information to any party, upon request, in order to facilitate such party’s ability to seek and obtain all known patent licenses necessary to implement a Final Standard in a Licensee’s Product. 6.2CDISC Patent Disclaimers. After CDISC’s adoption of the CDISC IP Policy,all published Final Standards shall include the following disclaimers (or their equivalent):“It is possible that implementation of and compliance with this standard may require use of subject matter covered by patent rights. By publication of this standard, no position is taken with respect to the existence or validity of any claim or of any patent rights in connection therewith. CDISC, including the CDISC Board of Directors, shall not be responsible for identifying patent claims for which a license may be required in order to implement this standard or for conducting inquiries into the legal validity or scope of those patents or patent claims that are brought to its attention.”In addition, when CDISC receives from a patent rights holder a written licensing declaration indicating that a license will be required from such patent rights holder by implementers of a Final Standard, then such published Final Standard shall also add the following statement to the end of the above disclaimer:“Certain patent rights holders have filed a statement of willingness to grant a patent license to all implementers of this standard, consistent with the requirements of the CDISC Intellectual Property Policy. CDISC, including the CDISC Board of Directors, makes no representation as to the reasonableness of any terms or conditions of the license agreements offered by such patent rights holders, and all negotiations regarding such terms and conditions must take place between the individual parties outside the context of CDISC. Further information regarding those parties who have claimed patent rights in the standard and expressed their willingness to provide a license may be obtained from the CDISC President. The user should be aware, however, that it is also possible that other patent rights that have not been disclosed to CDISC may be implicated by implementation of or compliance with the standard.” 6.3CDISC Statements Regarding General Disclaimers, Limitation of Liability, and Copyright License to End Users. All published Final Standards shall also include statements of warranty, disclaimer, and limitation of liability statements substantially similar to those in Section 9.4 and Section 9.5, as well as a copyright notice to end users consistent with Section 1. 7 ConfidentialityAll Contributions and information disclosed as a part of CDISC activities shall be deemed non-confidential, and neither CDISC nor any Participant or Representative assumes any confidentiality obligations. 8 Withdrawal/Termination 8.1A Participant may withdraw from CDISC, or from any CDISC Group, at any time by sending a written notice to CDISC. Withdrawal shall be effective upon receipt of such written notice by CDISC. 8.2Effect of Withdrawal/Termination. Notwithstanding the Participant’s withdrawal or termination, and except (as applicable) as provided in Section 5.1 or Section 8.3, a Participant’s agreement to grant a license under Section 3 or Section 5.1 (as applicable) shall remain in full force and effect for: (1) Necessary Claims covering a Contribution made by the withdrawing/terminating Participant that is incorporated into a Final Standard to which such Contribution was offered (even if such Final Standard is adopted after such Participant’s withdrawal/termination); or (2) Non-Contributed Necessary Claims covering a Final Standard as such Final Standard (or the Draft Standard from which it arose) existed on the date of withdrawal/termination (even if such Final Standard is adopted after such Participant’s withdrawal/termination); and (3) Necessary Claims covering a Final Standard adopted by CDISC after the effective date of the Participant’s withdrawal/termination that: (i) are necessary for the later-adopted Final Standard to be backwards compatible with a prior Final Standard; and (ii) are used in a substantially similar manner, extent, and result as such Necessary Claims were used in such prior Final Standard for which the Participant is obligated to grant licenses. All rights and obligations of the withdrawn/terminated Participant other than those specifically referenced in this Section 8.2 or Section 3, 5.1, or 4.2 shall cease upon such withdrawal/termination. 9 General 9.1 No Other Licenses. Except for the rights expressly provided under this Policy, neither CDISC nor any Participant grants or receives, by implication, estoppel, or otherwise, any rights under any patents, copyrights, or other intellectual property rights. 9.2 No Software Code in Required Portions of Standards. Except for data interchange formats, no Draft Standard or Final Standard, and no Contribution, may include software code (i.e., source code or object code), except for code that will be used for illustrative purposes only and will not be deemed to be a Required Portion of a Draft Standard or Final Standard. 9.3 Representations and Warranties. Each Participant shall be deemed to represent, warrant, and covenant, at the time of a Contribution by such Participant (or by its Representative), that to the best of its knowledge and ability: (a) it holds or has the right to grant all relevant licenses to any of its Contributions in all jurisdictions or territories in which it holds relevant intellectual property rights; (b) there are no limits to the Participant’s ability to make the grants, acknowledgments, and agreements herein; and (c) the Contribution does not subject any Contribution, Draft Standard, Final Standard, or implementations thereof, in whole or in part, to licensing obligations with additional restrictions or requirements inconsistent with those set forth in this Policy, or that would require any such Contribution, Final Standard, or implementation, in whole or in part, to be either: (i) disclosed or distributed in source code form; (ii) licensed for the purpose of making derivative works (other than as set forth in Section 4.2); or (iii) distributed at no charge, except as set forth in Sections 3, 5.1, and 4.2. If a Participant has knowledge that a Contribution made by any Participant or any other party may subject any Contribution, Draft Standard, Final Standard, or implementation, in whole or in part, to one or more of the licensing obligations listed in Section 9.3, such Participant shall give prompt notice of the same to the CDISC President who shall promptly notify all Participants. 9.4 No Other Warranties/Disclaimers. ALL PARTICIPANTS ACKNOWLEDGE THAT, EXCEPT AS PROVIDED UNDER SECTION 9.3, ALL DRAFT STANDARDS AND FINAL STANDARDS, AND ALL CONTRIBUTIONS TO FINAL STANDARDS AND DRAFT STANDARDS, ARE PROVIDED “AS IS” WITH NO WARRANTIES WHATSOEVER, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, AND THE PARTICIPANTS, REPRESENTATIVES , THE CDISC PRESIDENT, THE CDISC BOARD OF DIRECTORS, AND CDISC EXPRESSLY DISCLAIM ANY WARRANTY OF MERCHANTABILITY, NONINFRINGEMENT, FITNESS FOR ANY PARTICULAR OR INTENDED PURPOSE, OR ANY OTHER WARRANTY OTHERWISE ARISING OUT OF ANY PROPOSAL, FINAL STANDARDS OR DRAFT STANDARDS, OR CONTRIBUTION. 9.5 Limitation of Liability . IN NO EVENT WILL CDISC OR ANY OF ITS CONSTITUENT PARTS (INCLUDING, BUT NOT LIMITED TO, THE CDISC BOARD OF DIRECTORS, THE CDISC PRESIDENT, CDISC STAFF, AND CDISC MEMBERS) BE LIABLE TO ANY OTHER PERSON OR ENTITY FOR ANY LOSS OF PROFITS, LOSS OF USE, DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES, WHETHER UNDER CONTRACT, TORT, WARRANTY, OR OTHERWISE, ARISING IN ANY WAY OUT OF THIS POLICY OR ANY RELATED AGREEMENT, WHETHER OR NOT SUCH PARTY HAD ADVANCE NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. 9.6 Publicity. Each Participant consents to the public disclosure and use of its name for purposes of publicly promoting Final Standards, including the use in statements regarding the compliance of the Participant’s Licensee’s Products with a Final Standard, unless such Participant explicitly indicates in writing to the CDISC President such Participant’s refusal to consent to such public disclosure and use of its name. 9.7 Governing Law / Jurisdiction / Venue. This Policy shall be construed and controlled by the laws of the State of Delaware without giving effect to conflict-of-law principles. The parties agree that all disputes arising in any way out of this Policy will be heard exclusively in, and all parties irrevocably consent to jurisdiction and venue in, the state and Federal courts of the State of Delaware. 9.8 Complete Agreement. This Policy (including all documents referenced herein) sets forth the entire understanding between CDISC and its Members and Participants and Representatives regarding the treatment of patent, copyright, and related issues and supersedes all prior agreements, representations, and understandings related thereto. 10 AuthorizationThis document has been approved and is in effect on this date: Name CDISC Board of Directors Date 11 Change ControlThis Policy is the complete and exclusive statement of the Clinical Data Interchange Standards Consortium, Inc.’s (“CDISC”) Intellectual Property policy, consistent with the CDISC Bylaws. Once this Policy has been approved by the CDISC Board of Directors, it will apply to Members and other parties to the extent they are Participants in one or more CDISC Groups. Any future revisions to this Policy (or any document referenced herein) will become effective only upon approval of such revisions by the CDISC Board and only after: (a) CDISC notifies all Members and Participants in writing (such as by e-mail) of such revisions; (b) a clear and conspicuous link to the revised Policy, with the revisions highlighted, is posted on the home page of the CDISC website (currently http://www.cdisc.org/) for all existing Members/Participants and potential new Members/Participants to see; and (c) Participants are afforded at least thirty (30) calendar days from the date of receiving notice of such revisions to withdraw from CDISC or from particular CDISC Groups; provided, however, that ministerial changes to this Policy, such as proofreading corrections or formatting changes, may be executed by the CDISC Board and, upon CDISC Board approval, shall be immediately effective as to all existing and new Participants, so long as a revised version of the Policy containing such ministerial changes is posted on the home page of the CDISC website. Any Participant that withdraws from CDISC or from a CDISC Group prior to the end of this thirty (30)-day period will be subject to the version of the Policy that was in effect prior to the Board-approved revisions, in accordance with its terms and the withdrawal provisions of such version, but will not be subject to new or revised terms of the revised Policy. Any existing Participant that does not so withdraw prior to the end of this thirty (30)-day period will be deemed to have ratified and accepted the revised Policy in its entirety even without written agreement to such revised Policy by such Participant.

Link

https://www.cdisc.org/standards/foundational/sdtmig

Keywords

  1. 3/9/20 3/9/20 -
  2. 11/5/20 11/5/20 -
  3. 4/13/21 4/13/21 - Dr. rer. medic Philipp Neuhaus
  4. 6/18/21 6/18/21 - Sarah Riepenhausen
  5. 6/21/21 6/21/21 - Sarah Riepenhausen
  6. 9/20/21 9/20/21 -
  7. 9/27/21 9/27/21 -
Copyright Holder

CDISC

Uploaded on

March 9, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

CDISC SDTM

Observation Class: Events - Domain: Medical History

  1. StudyEvent: ODM
    1. Observation Class: Special Purpose - Domain: Comments
    2. Observation Class: Special Purpose - Domain: Demographics
    3. Observation Class: Special Purpose - Domain: Subject Elements
    4. Observation Class: Special Purpose - Domain: Subject Disease Milestones
    5. Observation Class: Special Purpose - Domain: Subject Visits
    6. Observation Class: Interventions - Domain: Procedure Agents
    7. Observation Class: Interventions - Domain: Concomitant/Prior Medications
    8. Observation Class: Interventions - Domain: Exposure
    9. Observation Class: Interventions - Domain: Exposure as Collected
    10. Observation Class: Interventions - Domain: Meal Data
    11. Observation Class: Interventions - Domain: Procedures
    12. Observation Class: Interventions - Domain: Substance Use
    13. Observation Class: Events - Domain: Adverse Events
    14. Observation Class: Events - Domain: Clinical Events
    15. Observation Class: Events - Domain: Disposition
    16. Observation Class: Events - Domain: Protocol Deviations
    17. Observation Class: Events - Domain: Healthcare Encounters
    18. Observation Class: Events - Domain: Medical History
    19. Observation Class: Findings - Domain: Drug Accountability
    20. Observation Class: Findings - Domain: Death Details
    21. Observation Class: Findings - Domain: ECG Test Results
    22. Observation Class: Findings - Domain: Inclusion/Exclusion Criteria Not Met
    23. Observation Class: Findings - Domain: Immunogenicity Specimen Assessments
    24. Observation Class: Findings - Domain: Laboratory Test Results
    25. Observation Class: Findings - Domain: Microbiology Specimen
    26. Observation Class: Findings - Domain: Microbiology Susceptibility
    27. Observation Class: Findings - Domain: Microscopic Findings
    28. Observation Class: Findings - Domain: Morphology
    29. Observation Class: Findings - Domain: Cardiovascular System Findings
    30. Observation Class: Findings - Domain: Musculoskeletal System Findings
    31. Observation Class: Findings - Domain: Nervous System Findings
    32. Observation Class: Findings - Domain: Ophthalmic Examinations
    33. Observation Class: Findings - Domain: Reproductive System Findings
    34. Observation Class: Findings - Domain: Respiratory System Findings
    35. Observation Class: Findings - Domain: Urinary System Findings
    36. Observation Class: Findings - Domain: Pharmacokinetics Concentrations
    37. Observation Class: Findings - Domain: Pharmacokinetics Parameters
    38. Observation Class: Findings - Domain: Physical Examination
    39. Observation Class: Findings - Domain: Functional Tests
    40. Observation Class: Findings - Domain: Questionnaires
    41. Observation Class: Findings - Domain: Disease Response and Clin Classification
    42. Observation Class: Findings - Domain: Subject Characteristics
    43. Observation Class: Findings - Domain: Subject Status
    44. Observation Class: Findings - Domain: Tumor/Lesion Identification
    45. Observation Class: Findings - Domain: Tumor/Lesion Results
    46. Observation Class: Findings - Domain: Vital Signs
    47. Observation Class: Findings - Domain: Findings About Events or Interventions
    48. Observation Class: Findings - Domain: Skin Response
    49. Observation Class: Trial Design - Domain: Trial Arms
    50. Observation Class: Trial Design - Domain: Trial Elements
    51. Observation Class: Trial Design - Domain: Trial Visits
    52. Observation Class: Trial Design - Domain: Trial Disease Assessments
    53. Observation Class: Trial Design - Domain: Trial Disease Milestones
    54. Observation Class: Trial Design - Domain: Trial Inclusion/Exclusion Criteria
    55. Observation Class: Trial Design - Domain: Trial Summary Information
    56. Observation Class: Relationships - Domain: Related Records
    57. Observation Class: Relationships - Domain: Supplemental Qualifiers for [domain name]
    58. Observation Class: Relationships - Domain: Related Subjects
    59. Observation Class: Study Reference - Domain: Non-host Organism Identifiers
Medical History
Description

Medical History

Alias
SDTMIG v3.3
MH
UMLS CUI-1
C0262926
NCIt V19.10d:
C49603
Study Identifier
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Unique identifier for a study. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1]
C2826693
SDTMIG 3.3
STUDYID
NCIt V19.10d
C83082
Domain Abbreviation
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Two-character abbreviation for the domain. Controlled Terms or Format (if applicable): MH

Data type

text

Alias
UMLS CUI [1,1]
C1883204
UMLS CUI [1,2]
C0000723
SDTMIG 3.3
DOMAIN
NCIt V19.10d
C49556
Unique Subject Identifier
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Identifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C1710548
UMLS CUI [1,2]
C2826693
SDTMIG 3.3
USUBJID
NCIt V19.10d
C70731
Sequence Number
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Sequence Number given to ensure uniqueness of subject records within a domain. May be any valid number. Controlled Terms or Format (if applicable): NA

Data type

integer

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C2348184
SDTMIG 3.3
MHSEQ
NCIt V19.10d
C83336
Group ID
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Used to tie together a block of related records in a single domain for a subject. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0441833
UMLS CUI [1,3]
C0600091
SDTMIG 3.3
MHGRPID
NCIt V19.10d
C83332
Reference ID
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Internal or external medical history identifier. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C2826265
SDTMIG 3.3
MHREFID
NCIt V19.10d
C83332
Sponsor-Defined Identifier
Description

Role: Identifier CDISC Notes (for domains) Description (for General Classes): Sponsor-defined reference number. Perhaps preprinted on the CRF as an explicit line identifier or defined in the sponsor's operational database. Example: Line number on a Medical History page. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C2347796
UMLS CUI [1,3]
C0600091
SDTMIG 3.3
MHSPID
NCIt V19.10d
C83079
Reported Term for the Medical History
Description

Role: Topic CDISC Notes (for domains) Description (for General Classes): Verbatim or preprinted CRF term for the medical condition or event. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C2826302
UMLS CUI [1,2]
C0262926
SDTMIG 3.3
MHTERM
NCIt V19.10d
C83118
Modified Reported Term
Description

Role: Synonym Qualifier CDISC Notes (for domains) Description (for General Classes): If MHTERM is modified to facilitate coding, then MHMODIFY will contain the modified text. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0392747
UMLS CUI [1,3]
C2826302
SDTMIG 3.3
MHMODIFY
NCIt V19.10d
C83333
Dictionary-Derived Term
Description

Role: Synonym Qualifier CDISC Notes (for domains) Description (for General Classes): Dictionary-derived text description of MHTERM or MHMODIFY. Equivalent to the Preferred Term (PT in MedDRA). The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the external codelist element in the Define-XML document. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C2826605
SDTMIG 3.3
MHDECOD
NCIt V19.10d
C83346
Medical History Event Date Type
Description

Role: Variable Qualifier CDISC Notes (for domains) Description (for General Classes): Specifies the aspect of the medical condition or event by which MHSTDTC and/or the MHENDTC is defined. Examples: "DIAGNOSIS", "SYMPTOMS", "RELAPSE", "INFECTION". Controlled Terms or Format (if applicable): (MHEDTTYP), extensible

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0332307
SDTMIG 3.3
MHEVDTYP
Category for Medical History
Description

Role: Grouping Qualifier CDISC Notes (for domains) Description (for General Classes): Used to define a category of related records. Examples: "CARDIAC" or "GENERAL". Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C0262926
SDTMIG 3.3
MHCAT
NCIt V19.10d
C83018
Subcategory for Medical History
Description

Role: Grouping Qualifier CDISC Notes (for domains) Description (for General Classes): A further categorization of the condition or event. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C1515010
SDTMIG 3.3
MHSCAT
NCIt V19.10d
C83143
Medical History Event Pre-Specified
Description

Role: Variable Qualifier CDISC Notes (for domains) Description (for General Classes): A value of "Y" indicates that this medical history event was pre-specified on the CRF. Values are null for spontaneously reported events (i.e., those collected as free-text verbatim terms). Controlled Terms or Format (if applicable): (NY), not extensible

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0441471
UMLS CUI [1,3]
C2826245
SDTMIG 3.3
MHPRESP
NCIt V19.10d
C87897
Medical History Occurrence
Description

Role: Record Qualifier CDISC Notes (for domains) Description (for General Classes): Used when the occurrence of specific medical history conditions is solicited, to indicate whether or not ("Y"/"N") a medical condition (MHTERM) had ever occurred. Values are null for spontaneously reported events. Controlled Terms or Format (if applicable): (NY), not extensible

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C2745955
SDTMIG 3.3
MHOCCUR
NCIt V19.10d
C83067
Completion Status
Description

Role: Record Qualifier CDISC Notes (for domains) Description (for General Classes): The status indicates that the pre-specified question was not asked/answered. Controlled Terms or Format (if applicable): (ND)

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0805732
UMLS CUI [1,3]
C1522634
SDTMIG 3.3
MHSTAT
NCIt V19.910d
C83337
Reason Medical History Not Collected
Description

Role: Record Qualifier CDISC Notes (for domains) Description (for General Classes): Describes the reason why data for a pre-specified condition was not collected. Used in conjunction with MHSTAT when value is "NOT DONE". Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C2826287
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C1516698
SDTMIG 3.3
MHREASND
NCIt V19.10d
C83334
Body System or Organ Class
Description

Role: Record Qualifier CDISC Notes (for domains) Description (for General Classes): Dictionary-derived. Body system or organ class that is involved in an event or measurement from a standard hierarchy (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for the sponsor's analyses and summary tables which may not necessarily be the primary SOC. Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0460002
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0178784
UMLS CUI [2,3]
C0456387
SDTMIG 3.3
MHBODSYS
Planned Order of Element within Arm
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Number that gives the planned order of the Element within the Arm for the Element in which the assessment was made. Controlled Terms or Format (if applicable): NA

Data type

integer

Alias
UMLS CUI [1,1]
C1301732
UMLS CUI [1,2]
C1705175
UMLS CUI [1,3]
C3812827
UMLS CUI [1,4]
C1522541
SDTMIG 3.3
TAETORD
NCIt V19.10d
C83438
Epoch
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Epoch associated with the start date/time of the medical history event. Controlled Terms or Format (if applicable): (EPOCH), extensible

Data type

text

Alias
UMLS CUI [1]
C2347803
SDTMIG 3.3
EPOCH
NCIt V19.10d
C71738
Date/Time of History Collection
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Collection date and time of the medical history observation represented in ISO 8601 character format. Controlled Terms or Format (if applicable): ISO 8601

Data type

datetime

Alias
UMLS CUI [1,1]
C1264639
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C1516698
SDTMIG 3.3
MHDTC
NCIt V19.10d
C83328
Start Date/Time of Medical History Event
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Start date/time of the medical history event represented in ISO 8601 character format. Controlled Terms or Format (if applicable): ISO 8601

Data type

datetime

Alias
UMLS CUI [1]
C2826928
SDTMIG 3.3
MHSTDTC
NCIt V19.10d
C83338
End Date/Time of Medical History Event
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): End date/time of the medical history event. Controlled Terms or Format (if applicable): ISO 8601

Data type

datetime

Alias
UMLS CUI [1]
C2826920
SDTMIG 3.3
MHENDTC
NCIt V19.10d
C83330
Study Day of History Collection
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): 1. Study day of medical history collection, measured as integer days. 2. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the submission. Controlled Terms or Format (if applicable): NA

Data type

integer

Measurement units
  • d
Alias
UMLS CUI [1,1]
C2826182
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C1516698
SDTMIG 3.3
MHDY
NCIt V19.10d
C83329
d
End Relative to Reference Period
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Describes the end of the event relative to the sponsor-defined reference period. The sponsor-defined reference period is a continuous period of time defined by a discrete starting point and a discrete ending point (represented by RFSTDTC and RFENDTC in Demographics). Not all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing Variables. Controlled Terms or Format (if applicable): (STENRF), not extensible

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0439564
UMLS CUI [1,4]
C1709877
SDTMIG 3.3
MHENRF
NCIt V19.10d
C83331
End Relative to Reference Time Point
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Identifies the end of the event as being before or after the reference time point defined by variable MHENTPT. Not all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing Variables. Controlled Terms or Format (if applicable): (STENRF), not extensbile

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C0439564
UMLS CUI [1,4]
C1709877
UMLS CUI [1,5]
C2348792
SDTMIG 3.3
MHENRTPT
NCIt V19.10d
C87895
End Reference Time Point
Description

Role: Timing CDISC Notes (for domains) Description (for General Classes): Description or date/time in ISO 8601 character format of the reference point referred to by MHENRTPT. Examples: "2003-12-25" or "VISIT 2". Controlled Terms or Format (if applicable): NA

Data type

text

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0444930
UMLS CUI [1,3]
C1709877
UMLS CUI [1,4]
C2348792
SDTMIG 3.3
MHENTPT
NCIt V19.10d
C87896

Similar models

Observation Class: Events - Domain: Medical History

  1. StudyEvent: ODM
    1. Observation Class: Special Purpose - Domain: Comments
    2. Observation Class: Special Purpose - Domain: Demographics
    3. Observation Class: Special Purpose - Domain: Subject Elements
    4. Observation Class: Special Purpose - Domain: Subject Disease Milestones
    5. Observation Class: Special Purpose - Domain: Subject Visits
    6. Observation Class: Interventions - Domain: Procedure Agents
    7. Observation Class: Interventions - Domain: Concomitant/Prior Medications
    8. Observation Class: Interventions - Domain: Exposure
    9. Observation Class: Interventions - Domain: Exposure as Collected
    10. Observation Class: Interventions - Domain: Meal Data
    11. Observation Class: Interventions - Domain: Procedures
    12. Observation Class: Interventions - Domain: Substance Use
    13. Observation Class: Events - Domain: Adverse Events
    14. Observation Class: Events - Domain: Clinical Events
    15. Observation Class: Events - Domain: Disposition
    16. Observation Class: Events - Domain: Protocol Deviations
    17. Observation Class: Events - Domain: Healthcare Encounters
    18. Observation Class: Events - Domain: Medical History
    19. Observation Class: Findings - Domain: Drug Accountability
    20. Observation Class: Findings - Domain: Death Details
    21. Observation Class: Findings - Domain: ECG Test Results
    22. Observation Class: Findings - Domain: Inclusion/Exclusion Criteria Not Met
    23. Observation Class: Findings - Domain: Immunogenicity Specimen Assessments
    24. Observation Class: Findings - Domain: Laboratory Test Results
    25. Observation Class: Findings - Domain: Microbiology Specimen
    26. Observation Class: Findings - Domain: Microbiology Susceptibility
    27. Observation Class: Findings - Domain: Microscopic Findings
    28. Observation Class: Findings - Domain: Morphology
    29. Observation Class: Findings - Domain: Cardiovascular System Findings
    30. Observation Class: Findings - Domain: Musculoskeletal System Findings
    31. Observation Class: Findings - Domain: Nervous System Findings
    32. Observation Class: Findings - Domain: Ophthalmic Examinations
    33. Observation Class: Findings - Domain: Reproductive System Findings
    34. Observation Class: Findings - Domain: Respiratory System Findings
    35. Observation Class: Findings - Domain: Urinary System Findings
    36. Observation Class: Findings - Domain: Pharmacokinetics Concentrations
    37. Observation Class: Findings - Domain: Pharmacokinetics Parameters
    38. Observation Class: Findings - Domain: Physical Examination
    39. Observation Class: Findings - Domain: Functional Tests
    40. Observation Class: Findings - Domain: Questionnaires
    41. Observation Class: Findings - Domain: Disease Response and Clin Classification
    42. Observation Class: Findings - Domain: Subject Characteristics
    43. Observation Class: Findings - Domain: Subject Status
    44. Observation Class: Findings - Domain: Tumor/Lesion Identification
    45. Observation Class: Findings - Domain: Tumor/Lesion Results
    46. Observation Class: Findings - Domain: Vital Signs
    47. Observation Class: Findings - Domain: Findings About Events or Interventions
    48. Observation Class: Findings - Domain: Skin Response
    49. Observation Class: Trial Design - Domain: Trial Arms
    50. Observation Class: Trial Design - Domain: Trial Elements
    51. Observation Class: Trial Design - Domain: Trial Visits
    52. Observation Class: Trial Design - Domain: Trial Disease Assessments
    53. Observation Class: Trial Design - Domain: Trial Disease Milestones
    54. Observation Class: Trial Design - Domain: Trial Inclusion/Exclusion Criteria
    55. Observation Class: Trial Design - Domain: Trial Summary Information
    56. Observation Class: Relationships - Domain: Related Records
    57. Observation Class: Relationships - Domain: Supplemental Qualifiers for [domain name]
    58. Observation Class: Relationships - Domain: Related Subjects
    59. Observation Class: Study Reference - Domain: Non-host Organism Identifiers
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Medical History
MH (SDTMIG v3.3)
C0262926 (UMLS CUI-1)
C49603 (NCIt V19.10d:)
STUDYID
Item
Study Identifier
text
C2826693 (UMLS CUI [1])
STUDYID (SDTMIG 3.3)
C83082 (NCIt V19.10d)
DOMAIN
Item
Domain Abbreviation
text
C1883204 (UMLS CUI [1,1])
C0000723 (UMLS CUI [1,2])
DOMAIN (SDTMIG 3.3)
C49556 (NCIt V19.10d)
USUBJID
Item
Unique Subject Identifier
text
C1710548 (UMLS CUI [1,1])
C2826693 (UMLS CUI [1,2])
USUBJID (SDTMIG 3.3)
C70731 (NCIt V19.10d)
SEQ
Item
Sequence Number
integer
C0262926 (UMLS CUI [1,1])
C2348184 (UMLS CUI [1,2])
MHSEQ (SDTMIG 3.3)
C83336 (NCIt V19.10d)
GRPID
Item
Group ID
text
C0262926 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
MHGRPID (SDTMIG 3.3)
C83332 (NCIt V19.10d)
REFID
Item
Reference ID
text
C0262926 (UMLS CUI [1,1])
C2826265 (UMLS CUI [1,2])
MHREFID (SDTMIG 3.3)
C83332 (NCIt V19.10d)
SPID
Item
Sponsor-Defined Identifier
text
C0262926 (UMLS CUI [1,1])
C2347796 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
MHSPID (SDTMIG 3.3)
C83079 (NCIt V19.10d)
TERM
Item
Reported Term for the Medical History
text
C2826302 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
MHTERM (SDTMIG 3.3)
C83118 (NCIt V19.10d)
MODIFY
Item
Modified Reported Term
text
C0262926 (UMLS CUI [1,1])
C0392747 (UMLS CUI [1,2])
C2826302 (UMLS CUI [1,3])
MHMODIFY (SDTMIG 3.3)
C83333 (NCIt V19.10d)
DECOD
Item
Dictionary-Derived Term
text
C0262926 (UMLS CUI [1,1])
C2826605 (UMLS CUI [1,2])
MHDECOD (SDTMIG 3.3)
C83346 (NCIt V19.10d)
Item
Medical History Event Date Type
text
C0262926 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
MHEVDTYP (SDTMIG 3.3)
Code List
Medical History Event Date Type
CL Item
Diagnostic (DIAGNOSIS)
CL Item
EPISODE  (EPISODE )
CL Item
EXACERBATION  (EXACERBATION )
CL Item
SYMPTOM ONSET  (SYMPTOM ONSET )
CAT
Item
Category for Medical History
text
C0683312 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
MHCAT (SDTMIG 3.3)
C83018 (NCIt V19.10d)
SCAT
Item
Subcategory for Medical History
text
C0262926 (UMLS CUI [1,1])
C1515010 (UMLS CUI [1,2])
MHSCAT (SDTMIG 3.3)
C83143 (NCIt V19.10d)
Item
Medical History Event Pre-Specified
text
C0262926 (UMLS CUI [1,1])
C0441471 (UMLS CUI [1,2])
C2826245 (UMLS CUI [1,3])
MHPRESP (SDTMIG 3.3)
C87897 (NCIt V19.10d)
Code List
Medical History Event Pre-Specified
CL Item
No (N)
CL Item
NA; Not Applicable (NA)
CL Item
U; UNK; Unknown (U)
CL Item
Yes (Y)
Item
Medical History Occurrence
text
C0262926 (UMLS CUI [1,1])
C2745955 (UMLS CUI [1,2])
MHOCCUR (SDTMIG 3.3)
C83067 (NCIt V19.10d)
Code List
Medical History Occurrence
CL Item
No (N)
CL Item
NA; Not Applicable (NA)
CL Item
U; UNK; Unknown (U)
CL Item
Yes (Y)
STAT
Item
Completion Status
text
C0262926 (UMLS CUI [1,1])
C0805732 (UMLS CUI [1,2])
C1522634 (UMLS CUI [1,3])
MHSTAT (SDTMIG 3.3)
C83337 (NCIt V19.910d)
REASND
Item
Reason Medical History Not Collected
text
C2826287 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,3])
MHREASND (SDTMIG 3.3)
C83334 (NCIt V19.10d)
BODSYS
Item
Body System or Organ Class
text
C0262926 (UMLS CUI [1,1])
C0460002 (UMLS CUI [1,2])
C0262926 (UMLS CUI [2,1])
C0178784 (UMLS CUI [2,2])
C0456387 (UMLS CUI [2,3])
MHBODSYS (SDTMIG 3.3)
TAETORD
Item
Planned Order of Element within Arm
integer
C1301732 (UMLS CUI [1,1])
C1705175 (UMLS CUI [1,2])
C3812827 (UMLS CUI [1,3])
C1522541 (UMLS CUI [1,4])
TAETORD (SDTMIG 3.3)
C83438 (NCIt V19.10d)
Item
Epoch
text
C2347803 (UMLS CUI [1])
EPOCH (SDTMIG 3.3)
C71738 (NCIt V19.10d)
Code List
Epoch
CL Item
BASELINE  (BASELINE )
CL Item
BLINDED TREATMENT  (BLINDED TREATMENT )
CL Item
Continuation Phase (CONTINUATION TREATMENT)
CL Item
FOLLOW-UP  (FOLLOW-UP )
CL Item
Induction Phase; Intensive Phase (INDUCTION TREATMENT)
CL Item
LONG-TERM FOLLOW-UP  (LONG-TERM FOLLOW-UP )
CL Item
OPEN LABEL TREATMENT  (OPEN LABEL TREATMENT )
CL Item
RUN-IN  (RUN-IN )
CL Item
SCREENING  (SCREENING )
CL Item
TREATMENT  (TREATMENT )
CL Item
WASHOUT  (WASHOUT )
DTC
Item
Date/Time of History Collection
datetime
C1264639 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,3])
MHDTC (SDTMIG 3.3)
C83328 (NCIt V19.10d)
STDTC
Item
Start Date/Time of Medical History Event
datetime
C2826928 (UMLS CUI [1])
MHSTDTC (SDTMIG 3.3)
C83338 (NCIt V19.10d)
ENDTC
Item
End Date/Time of Medical History Event
datetime
C2826920 (UMLS CUI [1])
MHENDTC (SDTMIG 3.3)
C83330 (NCIt V19.10d)
DY
Item
Study Day of History Collection
integer
C2826182 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,3])
MHDY (SDTMIG 3.3)
C83329 (NCIt V19.10d)
Item
End Relative to Reference Period
text
C0262926 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0439564 (UMLS CUI [1,3])
C1709877 (UMLS CUI [1,4])
MHENRF (SDTMIG 3.3)
C83331 (NCIt V19.10d)
Code List
End Relative to Reference Period
CL Item
AFTER  (AFTER )
CL Item
BEFORE  (BEFORE )
CL Item
COINCItDENT  (COINCItDENT )
CL Item
DURING  (DURING )
CL Item
DURING/AFTER  (DURING/AFTER )
CL Item
Continuous (ONGOING)
CL Item
U; UNK; Unknown (UNKNOWN)
Item
End Relative to Reference Time Point
text
C0262926 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C0439564 (UMLS CUI [1,3])
C1709877 (UMLS CUI [1,4])
C2348792 (UMLS CUI [1,5])
MHENRTPT (SDTMIG 3.3)
C87895 (NCIt V19.10d)
Code List
End Relative to Reference Time Point
CL Item
AFTER  (AFTER )
CL Item
BEFORE  (BEFORE )
CL Item
COINCItDENT  (COINCItDENT )
CL Item
DURING  (DURING )
CL Item
DURING/AFTER  (DURING/AFTER )
CL Item
Continuous (ONGOING)
CL Item
U; UNK; Unknown (UNKNOWN)
ENTPT
Item
End Reference Time Point
text
C0262926 (UMLS CUI [1,1])
C0444930 (UMLS CUI [1,2])
C1709877 (UMLS CUI [1,3])
C2348792 (UMLS CUI [1,4])
MHENTPT (SDTMIG 3.3)
C87896 (NCIt V19.10d)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial